Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2020.1767585
Abstract: ABSTRACT Introduction The management of patients affected by autoimmune/idiopathic diseases has been revolutionized by the development of targeted therapies (TT). However, the use of TT is complicated by several adverse events, like opportunistic infections (OIs).… read more here.
Keywords: autoimmune idiopathic; management opportunistic; therapies autoimmune; management ... See more keywords